Myocardial response to infarction in the rat Morphometric measurement of infarct size and myocyte cellular hypertrophy, Am J Pathol, vol.118, pp.484-92, 1985. ,
Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Current heart failure reports, pp.267-76, 2012. ,
Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction, World Journal of Biological Chemistry, vol.1, issue.5, pp.69-80, 2010. ,
DOI : 10.4331/wjbc.v1.i5.69
Cardiac extracellular matrix remodeling: Fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC), Journal of Molecular and Cellular Cardiology, vol.48, issue.3, pp.544-553, 2010. ,
DOI : 10.1016/j.yjmcc.2009.06.018
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling, Pflugers Archiv : European journal of physiology, vol.466, pp.1113-1140, 2014. ,
The Mechanistic Basis of Infarct Healing, Antioxidants & Redox Signaling, vol.8, issue.11-12, pp.1907-1946, 2006. ,
DOI : 10.1089/ars.2006.8.1907
Left Ventricular Remodeling After Myocardial Infarction : Pathophysiology and Therapy, Circulation, vol.101, issue.25, pp.2981-2989, 2000. ,
DOI : 10.1161/01.CIR.101.25.2981
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window, Cardiovascular Research, vol.69, issue.3, pp.604-617, 2006. ,
DOI : 10.1016/j.cardiores.2005.10.002
Heart Failure, JACC: Heart Failure, vol.1, issue.1, pp.1-20, 2013. ,
DOI : 10.1016/j.jchf.2012.10.002
Approach to STEMI and NSTEMI. The Journal of the Association of Physicians of India, pp.19-25, 2011. ,
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC medical genomics, p.26, 2011. ,
Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis, Circ Cardiovasc Genet, vol.1, pp.31-38, 2008. ,
Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction, Functional & Integrative Genomics, vol.358, issue.3, pp.329-366, 2010. ,
DOI : 10.2174/187152507779315813
Transforming growth factor beta receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC medical genomics, p.83, 2011. ,
Systems-Based Approaches to Cardiovascular Biomarker Discovery, Circulation: Cardiovascular Genetics, vol.5, issue.3, pp.360-367, 2012. ,
DOI : 10.1161/CIRCGENETICS.112.962977
miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?, Trends in Molecular Medicine, vol.20, issue.12, pp.716-741, 2014. ,
DOI : 10.1016/j.molmed.2014.10.006
Cardiac Troponin T, Circulation Journal, vol.77, issue.7, pp.1653-61, 2013. ,
DOI : 10.1253/circj.CJ-13-0706
Biology of the troponin complex in cardiac myocytes, Progress in Cardiovascular Diseases, vol.47, issue.3, pp.159-76, 2004. ,
DOI : 10.1016/j.pcad.2004.07.003
Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay, Clinical Chemistry, vol.56, issue.2, pp.254-61, 2010. ,
DOI : 10.1373/clinchem.2009.132654
Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays, New England Journal of Medicine, vol.361, issue.9, pp.858-67, 2009. ,
DOI : 10.1056/NEJMoa0900428
Biomarkers in acute myocardial infarction, BMC Medicine, vol.105, issue.1, p.34, 2010. ,
DOI : 10.1161/01.CIR.0000015464.18023.0A
Risk stratification of acute coronary syndromes] Annales de cardiologie et d'angeiologie, pp.16-20, 2007. ,
Biomarkers in Heart Failure, New England Journal of Medicine, vol.358, issue.20, pp.2148-59, 2008. ,
DOI : 10.1056/NEJMra0800239
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) European heart journal, pp.2569-619, 2012. ,
Galectin-3: A new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure, Archives of Cardiovascular Diseases, vol.106, issue.10, pp.541-547, 2013. ,
DOI : 10.1016/j.acvd.2013.06.054
A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis? Journal of cellular and molecular medicine, pp.2189-97, 2014. ,
PTH: Potential role in management of heart failure, Clinica Chimica Acta, vol.433, pp.290-296, 2014. ,
DOI : 10.1016/j.cca.2014.03.029
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery, Nucleic Acids Research, vol.6, issue.10, pp.1128-1164, 2012. ,
DOI : 10.1038/nrd2443
Aldosterone antagonists in the treatment of hypertension and target organ damage. Current hypertension reports, pp.240-248, 2001. ,
Aldosterone as a Mediator in Cardiovascular Injury, Cardiology in Review, vol.10, issue.2, pp.97-107, 2002. ,
DOI : 10.1097/00045415-200203000-00008
Using ACE inhibitors appropriately, American family physician, vol.66, pp.461-469, 2002. ,
Novel inhibitors of factor X for use in cardiovascular diseases, Current Cardiology Reports, vol.292, issue.Suppl 1, pp.395-404, 2000. ,
DOI : 10.1161/01.CIR.92.3.485
The GSK-3 family as therapeutic target for myocardial diseases. Circulation research, pp.138-187, 2015. ,
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure, Circulation, vol.124, issue.3, pp.304-317, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.022889
An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure, Circulation Research, vol.112, issue.5, pp.816-841, 2013. ,
DOI : 10.1161/CIRCRESAHA.111.300440
Gene Therapy to Treat Cardiovascular Disease, Journal of the American Heart Association, vol.2, issue.4, p.119, 2013. ,
DOI : 10.1161/JAHA.113.000119
Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks, Trends in Biotechnology, vol.17, issue.4, pp.169-74, 1999. ,
DOI : 10.1016/S0167-7799(98)01291-8
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer, Blood, vol.119, issue.13, pp.3038-3079, 2012. ,
DOI : 10.1182/blood-2011-09-382317
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo., Proceedings of the National Academy of Sciences, vol.90, issue.24, pp.11498-502, 1993. ,
DOI : 10.1073/pnas.90.24.11498
Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin, Gene Therapy, vol.5, issue.5, pp.630-634, 1998. ,
DOI : 10.1038/sj.gt.3300649
Targeted Modification of Atrial Electrophysiology by Homogeneous Transmural Atrial Gene Transfer, Circulation, vol.111, issue.3, pp.264-70, 2005. ,
DOI : 10.1161/01.CIR.0000153338.47507.83
The structure and function of chromatin Advances in human genetics, pp.237-431, 1972. ,
Collection of mRNA-like non-coding RNAs, Nucleic Acids Research, vol.32, issue.5, pp.192-197, 1999. ,
DOI : 10.1007/BF00020478
An integrated encyclopedia of DNA elements in the human genome, Nature, vol.489, pp.57-74, 2012. ,
Long non-coding RNAs: insights into functions, Nature Reviews Genetics, vol.72, issue.3 ,
DOI : 10.1093/oxfordjournals.molbev.a003951
MicroRNA expression profiles classify human cancers, Nature, vol.1, issue.7043, pp.834-842, 2005. ,
DOI : 10.1016/S1535-6108(02)00018-1
MicroRNAs and HIV-1 Infection: Antiviral Activities and Beyond, Journal of Molecular Biology, vol.426, issue.6, pp.1178-97, 2014. ,
DOI : 10.1016/j.jmb.2013.12.017
The involvement of microRNAs in neurodegenerative diseases, Frontiers in Cellular Neuroscience, vol.7, p.265, 2013. ,
DOI : 10.3389/fncel.2013.00265
MicroRNAs: novel regulators in cardiac development and disease. Cardiovascular research, pp.562-70, 2008. ,
MicroRNAs expression profiles in cardiovascular diseases BioMed research international, p.985408, 2014. ,
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation, Science, vol.35, issue.7, pp.1931-1935, 2007. ,
DOI : 10.1093/nar/gkm133
Many roads to maturity: microRNA biogenesis pathways and their regulation, Nature Cell Biology, vol.11, issue.3, pp.228-262, 2009. ,
DOI : 10.1126/science.1138050
Stability of miRNA in human urine supports its biomarker potential, Biomarkers in Medicine, vol.3, issue.4, pp.623-654, 2013. ,
DOI : 10.1073/pnas.0403453101
Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.579, issue.26, pp.10513-10521, 2008. ,
DOI : 10.1016/j.febslet.2005.09.039
Argonaute proteins regulate microRNA stability: ???Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization, RNA Biology, vol.8, issue.6, pp.1149-57, 2011. ,
DOI : 10.4161/rna.8.6.17665
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences, vol.16, issue.8, pp.5003-5011, 2011. ,
DOI : 10.1105/tpc.104.023614
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature Cell Biology, vol.257, issue.4, pp.423-456, 2011. ,
DOI : 10.1073/pnas.011404098
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes, Blood, vol.119, issue.3, pp.756-66, 2012. ,
DOI : 10.1182/blood-2011-02-338004
Detection of microRNA Expression in Human Peripheral Blood Microvesicles, PLoS ONE, vol.15, issue.11, p.3694, 2008. ,
DOI : 10.1371/journal.pone.0003694.s003
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection, Science Signaling, vol.2, issue.100, p.81, 2009. ,
DOI : 10.1126/scisignal.2000610
Serum MicroRNAs Are Promising Novel Biomarkers, PLoS ONE, vol.196, issue.2, p.3148, 2008. ,
DOI : 10.1371/journal.pone.0003148.t001
Potential therapeutic role of microRNAs in ischemic heart disease, Journal of Cardiology, vol.61, issue.5, pp.315-335, 2013. ,
DOI : 10.1016/j.jjcc.2013.01.012
Therapeutic Advances in MicroRNA Targeting, Journal of Cardiovascular Pharmacology, vol.57, issue.1, pp.1-7, 2011. ,
DOI : 10.1097/FJC.0b013e3181f603d0
Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circulation research, pp.235-43919, 2007. ,
microRNA therapeutics in cardiovascular disease models. Annual review of pharmacology and toxicology, pp.185-203, 2014. ,
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells, Nature Methods, vol.18, issue.9, pp.721-727, 2007. ,
DOI : 10.1038/nmeth1079
lncRNAdb: a reference database for long noncoding RNAs, Nucleic Acids Research, vol.104, issue.suppl_1, pp.146-51, 2011. ,
DOI : 10.1073/pnas.0702431104
NONCODEv4: exploring the world of long non-coding RNA genes, Nucleic Acids Research, vol.42, issue.D1, pp.98-103, 2014. ,
DOI : 10.1093/nar/gkt1057
Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, vol.5, issue.7308, pp.835-840, 2010. ,
DOI : 10.1038/nature09267
URL : http://europepmc.org/articles/pmc2990499?pdf=render
On the classification of long non-coding RNAs, RNA Biology, vol.5, issue.6, pp.925-958, 2013. ,
DOI : 10.1126/scisignal.2000568
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function, Trends in Genetics, vol.22, issue.1, pp.1-5, 2006. ,
DOI : 10.1016/j.tig.2005.10.003
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression, Proceedings of the National Academy of Sciences, vol.106, issue.28, pp.11667-72, 2009. ,
DOI : 10.1101/gr.6036807
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity, Nature, vol.106, pp.705-715, 2009. ,
DOI : 10.1016/S0002-9440(10)64465-3
A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia, Circulation Research, vol.104, issue.4, pp.476-87, 2009. ,
DOI : 10.1161/CIRCRESAHA.108.185363
Silencing of microRNAs in vivo with ???antagomirs???, Nature, vol.33, issue.7068, pp.685-689, 2005. ,
DOI : 10.1093/nar/gki025
miR-874 regulates myocardial necrosis by targeting caspase-8, Cell Death & Disease, vol.4, issue.7, p.709, 2013. ,
DOI : 10.1038/nm.2282
Pervasive roles of microRNAs in cardiovascular biology, Nature, vol.327, issue.7330, pp.336-378, 2011. ,
DOI : 10.1126/science.1178178
MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure, Circulation, vol.116, issue.3, pp.258-67, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.107.687947
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts, Nature, vol.100, issue.7224, pp.980-984, 2008. ,
DOI : 10.1101/SQB.1997.062.01.021
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure, Circulation, vol.124, issue.14, pp.1537-1547, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.030932
Loss of MicroRNA-155 Protects the Heart From Pathological Cardiac Hypertrophy, Circulation Research, vol.114, issue.10, pp.1585-95, 2014. ,
DOI : 10.1161/CIRCRESAHA.114.303784
MicroRNA-24 Regulates Vascularity After Myocardial Infarction, Circulation, vol.124, issue.6, pp.720-750, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.039008
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets, Cell, vol.120, issue.1, pp.15-20, 2005. ,
DOI : 10.1016/j.cell.2004.12.035
Inhibition of miR-15 Protects Against Cardiac Ischemic InjuryNovelty and Significance, Circulation Research, vol.110, issue.1, pp.71-81, 2012. ,
DOI : 10.1161/CIRCRESAHA.111.244442
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function, Proceedings of the National Academy of Sciences, vol.7, issue.3, pp.17615-17620, 2012. ,
DOI : 10.1371/journal.pone.0033844
Unity is strength ??? A panel of 4 microRNAs decreases cardiomyocyte hypertrophy, International Journal of Cardiology, vol.182, pp.62-66, 2015. ,
DOI : 10.1016/j.ijcard.2014.12.065
Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model, Circulation, vol.128, issue.10, pp.1066-1075, 2013. ,
DOI : 10.1161/CIRCULATIONAHA.113.001904
Myosin Heavy Chain Isoform Expression in the Failing and Nonfailing Human Heart, Circulation Research, vol.86, issue.4, pp.386-90, 2000. ,
DOI : 10.1161/01.RES.86.4.386
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure, Proceedings of the National Academy of Sciences, vol.26, issue.10, pp.18255-60, 2006. ,
DOI : 10.1128/MCB.26.10.3875-3888.2006
miRNA expression in the failing human heart: Functional correlates, Journal of Molecular and Cellular Cardiology, vol.45, issue.2, pp.185-92, 2008. ,
DOI : 10.1016/j.yjmcc.2008.04.014
MiR423-5p As a Circulating Biomarker for Heart Failure, Circulation Research, vol.106, issue.6, pp.1035-1044, 2010. ,
DOI : 10.1161/CIRCRESAHA.110.218297
A comparative encyclopedia of DNA elements in the mouse genome, Nature, vol.46, issue.7527, pp.355-64, 2014. ,
DOI : 10.1038/ng.2965
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment, Cell, vol.152, issue.3, pp.570-83, 2013. ,
DOI : 10.1016/j.cell.2013.01.003
The Kcnq1ot1 Long Non-Coding RNA Affects Chromatin Conformation and Expression of Kcnq1, but Does Not Regulate Its Imprinting in the Developing Heart, PLoS Genetics, vol.8, issue.9, p.1002956, 2012. ,
DOI : 10.1371/journal.pgen.1002956.s009
Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction, Journal of Human Genetics, vol.278, issue.12, pp.1087-99, 2006. ,
DOI : 10.1007/s10038-006-0070-9
Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells, RNA, vol.16, issue.2, pp.324-361, 2010. ,
DOI : 10.1261/rna.1441510
Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment, The EMBO Journal, vol.136, issue.24, pp.3145-60, 2013. ,
DOI : 10.1242/dev.022087
Long noncoding RNAs in patients with acute myocardial infarction. Circulation research, pp.668-77, 2014. ,
Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochemical and biophysical research communications, pp.315-320, 2008. ,
Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a, Molecular Cell, vol.38, issue.5, pp.662-74, 2010. ,
DOI : 10.1016/j.molcel.2010.03.021
A Common Allele on Chromosome 9 Associated with Coronary Heart Disease, Science, vol.106, issue.4, pp.1488-91, 2007. ,
DOI : 10.1038/ng1984
Large-scale association analysis identifies new risk loci for coronary artery disease, Nat Genet, vol.45, pp.25-33, 2013. ,
The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10, Human Molecular Genetics, vol.21, issue.22, 2013. ,
DOI : 10.1093/bioinformatics/bth457
Molecular genetics of long QT syndrome, Molecular Genetics and Metabolism, vol.101, issue.1, pp.1-8, 2010. ,
DOI : 10.1016/j.ymgme.2010.05.011
Expression profiling and ontology analysis of long noncoding RNAs in post-ischemic heart and their implied roles in ischemia/reperfusion injury, Gene, vol.543, issue.1, pp.15-21, 2014. ,
DOI : 10.1016/j.gene.2014.04.016
CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation, Nature Communications, vol.69, p.3596, 2014. ,
DOI : 10.1158/0008-5472.CAN-08-2962
Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure, PLoS ONE, vol.28, issue.10, p.77938, 2013. ,
DOI : 10.1371/journal.pone.0077938.s006
Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support, Circulation, vol.129, issue.9, pp.1009-1021, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.113.003863
Characterization of human plasma-derived exosomal RNAs by deep sequencing, BMC Genomics, vol.14, issue.1, p.319, 2013. ,
DOI : 10.1093/bioinformatics/btm595
A long noncoding RNA protects the heart from pathological hypertrophy, Nature, vol.310, issue.7520, pp.102-108, 2014. ,
DOI : 10.1007/s11010-007-9683-3
Identification and initial functional characterization of a human vascular cellenriched long noncoding RNA. Arteriosclerosis, thrombosis, and vascular biology, pp.1249-59, 2014. ,
The smooth long noncoding RNA SENCR. Arteriosclerosis, thrombosis, and vascular biology, pp.1124-1129, 2014. ,
Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel GrowthNovelty and Significance, Circulation Research, vol.114, issue.9, pp.1389-97, 2014. ,
DOI : 10.1161/CIRCRESAHA.114.303265
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study, European Heart Journal, vol.28, issue.6, pp.711-719, 2007. ,
DOI : 10.1093/eurheartj/ehm003
Coronary Artery Ligation and Intramyocardial Injection in a Murine Model of Infarction, Journal of Visualized Experiments, issue.52, 2011. ,
DOI : 10.3791/2581
Assessment of myocardial viability by positron emission tomography, Nuclear Medicine Communications, vol.23, issue.4, pp.323-353, 2002. ,
DOI : 10.1097/00006231-200204000-00005
Imaging techniques in nuclear cardiology for the assessment of myocardial viability. The international journal of cardiovascular imaging, pp.63-80, 2006. ,
Application of annihilation coincidence detection to transaxial reconstruction tomography, J Nucl Med, vol.16, pp.210-234, 1975. ,
Acipimox-enhanced (18)F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model. The international journal of cardiovascular imaging, pp.1407-1415, 2012. ,
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart, Journal of Cardiovascular Magnetic Resonance, vol.4, issue.2, pp.539-581, 2002. ,
DOI : 10.1081/JCMR-120003946
High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease, Circulation, vol.126, issue.1, pp.31-40, 2012. ,
DOI : 10.1161/CIRCULATIONAHA.112.100867
MicroRNAs as biomarkers for myocardial infarction. Current atherosclerosis reports, pp.193-200, 2012. ,
Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction, European Heart Journal, vol.21, issue.18, pp.1514-1535, 2000. ,
DOI : 10.1053/euhj.1999.2045
MicroRNAs play an essential role in the development of cardiac hypertrophy. Circulation research, pp.416-440, 2007. ,
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction, European Heart Journal, vol.118, issue.22, pp.2765-73, 2010. ,
DOI : 10.1371/journal.pone.0002213
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome, Journal of Molecular and Cellular Cardiology, vol.51, issue.5, pp.872-875, 2011. ,
DOI : 10.1016/j.yjmcc.2011.07.011
Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction, BMC Cardiovascular Disorders, vol.51, issue.5, p.12, 2013. ,
DOI : 10.1016/j.yjmcc.2011.07.011
Universal Definition of Myocardial Infarction, Circulation, vol.116, issue.22, pp.2634-53, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.107.187397
A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochemical and biophysical research communications, pp.280-284, 2012. ,
Pooling serum samples may lead to loss of potential biomarkers in SELDI-ToF MS proteomic profiling., Proteome Science, vol.6, issue.1, p.16, 2008. ,
DOI : 10.1186/1477-5956-6-16
MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction. Disease markers, pp.259-65, 2011. ,
MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death, Cardiovascular Research, vol.45, issue.3, pp.387-97, 2015. ,
DOI : 10.1093/abbs/gmt067
Systemic Approach to Identify Serum microRNAs as Potential Biomarkers for Acute Myocardial Infarction, BioMed Research International, vol.62, issue.3, p.418628, 2014. ,
DOI : 10.1097/FJC.0b013e31829b82e6
Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration, Molecular Cell, vol.39, issue.1, pp.133-144, 2010. ,
DOI : 10.1016/j.molcel.2010.06.010
ECG-triggered (18)F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox. European journal of nuclear medicine and molecular imaging, pp.1745-1750, 2010. ,
Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study, European Journal of Heart Failure, vol.14, issue.10, pp.1157-1163, 2013. ,
DOI : 10.1161/CIRCHEARTFAILURE.112.000146
European Cardiovascular Disease Statistics, 2008. ,
Initial sequencing and analysis of the human genome, Nature, vol.6, issue.6822, pp.860-921, 2001. ,
DOI : 10.1089/cmb.1999.6.91
The Sequence of the Human Genome, Science, vol.6, issue.5507, pp.1304-1351, 2001. ,
DOI : 10.1093/nar/28.1.33
URL : https://hal.archives-ouvertes.fr/hal-00465088
Transcriptional Maps of 10 Human Chromosomes at 5-Nucleotide Resolution, Science, vol.308, issue.5725, pp.1149-1154, 2005. ,
DOI : 10.1126/science.1108625
An integrated encyclopedia of DNA elements in the human genome, Nature, vol.463, issue.7414, pp.57-74, 2012. ,
DOI : 10.1038/nature08795
Landscape of transcription in human cells, Nature, vol.474, issue.7414, pp.101-108, 2012. ,
DOI : 10.1038/nature10006
URL : https://hal.archives-ouvertes.fr/hal-01216755
Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, vol.5, issue.7308, pp.835-840, 2010. ,
DOI : 10.1038/nature09267
Targeting long non-coding RNA to therapeutically upregulate gene expression, Nature Reviews Drug Discovery, vol.28, issue.6, pp.433-446, 2013. ,
DOI : 10.1038/onc.2008.373
The transcriptional landscape of the mammalian genome, Science, vol.309, pp.1559-1563, 2005. ,
RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription, Science, vol.4, issue.6, pp.1484-1488, 2007. ,
DOI : 10.1016/0959-437X(94)90066-3
Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment, Cell, vol.152, issue.3, pp.570-583, 2013. ,
DOI : 10.1016/j.cell.2013.01.003
The Tissue-Specific lncRNA Fendrr Is an Essential Regulator of Heart and Body Wall Development in the Mouse, Developmental Cell, vol.24, issue.2, pp.206-214, 2013. ,
DOI : 10.1016/j.devcel.2012.12.012
Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction, Journal of Human Genetics, vol.278, issue.12, pp.1087-1099, 2006. ,
DOI : 10.1007/s10038-006-0070-9
Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure, PLoS ONE, vol.28, issue.10, p.77938, 2013. ,
DOI : 10.1371/journal.pone.0077938.s006
Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support, Circulation, vol.129, issue.9, pp.1009-1021, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.113.003863
ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox, European Journal of Nuclear Medicine and Molecular Imaging, vol.267, issue.6 Pt 1, pp.1745-1750, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.106.645184
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Professionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Circulation, vol.105, issue.4, pp.539-542, 2002. ,
DOI : 10.1161/hc0402.102975
Automatic quantification of ejection fraction from gated myocardial perfusion SPECT, J Nucl Med, vol.36, pp.2138-2147, 1995. ,
Use of within-array replicate spots for assessing differential expression in microarray experiments, Bioinformatics, vol.8, issue.6, pp.2067-2075, 2005. ,
DOI : 10.1089/106652701753307520
Variance stabilization applied to microarray data calibration and to the quantification of differential expression, Bioinformatics, vol.18, issue.Suppl 1, pp.96-104, 2002. ,
DOI : 10.1093/bioinformatics/18.suppl_1.S96
ClassDiscovery: Classes and methods for " class discovery " with microarrays or proteomics, 2009. ,
Significance analysis of microarrays applied to the ionizing radiation response, Proceedings of the National Academy of Sciences, vol.57, issue.2, pp.5116-5121, 2001. ,
DOI : 10.2307/3579583
Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.24, issue.2, pp.14863-14868, 1998. ,
DOI : 10.1016/0092-8674(81)90326-3
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists, Genome Biology, vol.8, issue.9, p.183, 2007. ,
DOI : 10.1186/gb-2007-8-9-r183
lncRNAdb: a reference database for long noncoding RNAs, Nucleic Acids Research, vol.104, issue.suppl_1, pp.146-151, 2011. ,
DOI : 10.1073/pnas.0702431104
NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins, Nucleic Acids Research, vol.33, issue.Database issue, pp.501-504, 2005. ,
DOI : 10.1093/nar/gki025
Ensembl 2011, Nucleic Acids Research, vol.15, issue.7, pp.800-806, 2011. ,
DOI : 10.1101/gr.3577405
BLAST+: architecture and applications, BMC Bioinformatics, vol.10, issue.1, p.421, 2009. ,
DOI : 10.1186/1471-2105-10-421
WGCNA: an R package for weighted correlation network analysis, BMC Bioinformatics, vol.9, issue.1, p.559, 2008. ,
DOI : 10.1186/1471-2105-9-559
Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers, Journal of Neurochemistry, vol.38, issue.3, pp.459-466, 2011. ,
DOI : 10.1016/j.biocel.2006.05.004
Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study, European Journal of Heart Failure, vol.14, issue.10, pp.1157-1163, 2013. ,
DOI : 10.1161/CIRCHEARTFAILURE.112.000146
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure: Data From CORONA and COACH, Circulation: Heart Failure, vol.6, issue.2, pp.219-226, 2013. ,
DOI : 10.1161/CIRCHEARTFAILURE.112.000129
Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction, Circulation: Heart Failure, vol.6, issue.3, pp.492-498, 2013. ,
DOI : 10.1161/CIRCHEARTFAILURE.112.000146